Conduit Pharmaceuticals I... (CDT)
2.60
-0.25 (-8.77%)
At close: Feb 10, 2025, 1:00 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY24 | FY23 | FY22 | FY21 |
| Revenue | 2.46B | n/a | n/a | n/a |
| Cost of Revenue | 1.54B | n/a | n/a | n/a |
| Gross Profit | 922.22M | n/a | n/a | n/a |
| Operating Income | 266.46M | -5.56M | -3.16M | -3.17M |
| Interest Income | n/a | 15.00K | 1.98M | n/a |
| Pretax Income | 227.94M | -535.00K | -4.89M | -3.66M |
| Net Income | 198.43M | -535.00K | -4.89M | -3.66M |
| Selling & General & Admin | 494.60M | 5.47M | 3.05M | 2.89M |
| Research & Development | 112.36M | 90.00K | 111.00K | 283.00K |
| Other Expenses | n/a | n/a | n/a | n/a |
| Operating Expenses | 606.97M | 5.56M | 3.16M | 3.17M |
| Interest Expense | -38.30M | 211.00K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
| Cost & Expenses | 2.15B | 5.56M | 3.16M | 3.17M |
| Income Tax | -29.53M | -167.90K | 374.86K | 247.44K |
| Shares Outstanding (Basic) | 40.69M | 66.97M | 17.29M | 17.29M |
| Shares Outstanding (Diluted) | 41.30M | 67.89M | 17.29M | 17.29M |
| EPS (Basic) | 4.88 | -0.09 | -0.28 | -0.21 |
| EPS (Diluted) | 4.80 | -0.09 | -0.28 | -0.21 |
| EBITDA | 266.46M | -324.00K | -1.43M | -4.38K |
| Depreciation & Amortization | n/a | 167.90K | 1.73M | 484.00K |